Literature DB >> 24085745

Red cell distribution width identifies cerebral venous sinus thrombosis in patients with headache.

Recep Demir1, Murat Saritemur2, Lutfi Ozel3, Gokhan Ozdemir3, Mucahit Emet2, Hizir Ulvi3.   

Abstract

BACKGROUND: Diagnosing cerebral venous sinus thrombosis (CVST) in patients referring to emergency service or neurology outpatient unit with complaints of headache is a challenging task. Magnetic resonance (MR) venography is the gold standard, but there are limitations regarding its use. AIM: To evaluate the validity of red cell distribution width (RDW) in CVST diagnosis in patients presenting with headache.
METHODS: A total of 138 patients comprising 37 patients with CVST and 101 control primer headache cases were included in this retrospective cross-sectional study. Control group consists of hospitalized patients with primary headache. Venous blood hemoglobin (Hb), platelet, mean corpuscular volume (MCV), RDW, fibrinogen, and vitamin B12 levels of the patients were recorded at the first referral. Diagnosis of CVST was established by MR venography.
RESULTS: The RDW ratio of patients with a diagnosis of CVST was significantly higher than that in patients with primary headache (15.3 ± 1.4 vs 13.3 ± 0.5; P <.0001). Fibrinogen and vitamin B12 levels were not significantly different between the 2 groups. In a total of 11 patients, there was more than 1 thrombosis. In 21 of the patients with CVST, gene mutation was detected. There was no significant difference between the patients with and without mutations regarding RDW values. Diagnostic validity of RDW was found to be excellent in differentiating patients with CVST and primary headache (area under the curve = 0.996; 95% CI: 0.990-1.000). Optimum RDW cutoff value was determined as 14.1% (sensitivity: 91.9%, specificity: 99%, positive predictive value: 92.8, negative predictive value: 0.082).
CONCLUSION: We suppose that among patients presenting with the complaint of headache, RDW value may lead to diagnose CVST.
© The Author(s) 2013.

Entities:  

Keywords:  cerebral venous sinus thrombosis; diagnosis; headache; marker; red cell distribution width

Mesh:

Year:  2013        PMID: 24085745     DOI: 10.1177/1076029613505764

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  6 in total

1.  Sensitivity and specificity of red cell distribution width in diagnosing acute mesenteric ischemia in patients with abdominal pain.

Authors:  Abdullah Kisaoglu; Atif Bayramoglu; Bunyami Ozogul; Kenan Atac; Mucahit Emet; Sabri Selcuk Atamanalp
Journal:  World J Surg       Date:  2014-11       Impact factor: 3.352

2.  Transient Ischemic Attack Versus Seizure: Use of Complete Blood Count Parameters for Differential Diagnosis.

Authors:  Necati Salman; Atif Bayramoglu; Onur Tezel; Yahya Ayhan Acar
Journal:  J Clin Diagn Res       Date:  2016-08-01

3.  Can we distinguish stroke and stroke mimics via red cell distribution width in young patients?

Authors:  Recep Demir; Murat Saritemur; Omer Atis; Lutfi Ozel; İdris Kocaturk; Mucahit Emet; Hizir Ulvi
Journal:  Arch Med Sci       Date:  2015-10-12       Impact factor: 3.318

4.  Is Migraine an MPV-Related Disease? An Observational Study of Polish Neurological Patients.

Authors:  Katarzyna Brzeźniakiewicz-Janus; Marcus D Lancé; Andrzej Tukiendorf; Joanna Rupa-Matysek; Sybilla Brzozowska-Mańkowska; Mirosław Franków; Edyta Wolny-Rokicka; Lidia Gil
Journal:  Dis Markers       Date:  2019-12-06       Impact factor: 3.434

5.  A prognostic nomogram incorporating red cell distribution width for patients with intracerebral hemorrhage.

Authors:  Zhe Cui; Chengwang Liu; Guozhong Sun; Liping Huang; Weiwen Zhou
Journal:  Medicine (Baltimore)       Date:  2020-12-11       Impact factor: 1.817

6.  Elevated Red Blood Cell Distribution Width May Be a Novel Independent Predictor of Poor Functional Outcome in Patients Treated with Mechanical Thrombectomy.

Authors:  Cetin Kursad Akpinar; Erdem Gurkaş; Ozlem Aykac; Zehra Uysal; Atilla Ozcan Ozdemir
Journal:  Neurointervention       Date:  2020-11-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.